Search

Your search keyword '"Bertagna, Francesco"' showing total 851 results
Start Over Author "Bertagna, Francesco" Language english
851 results on '"Bertagna, Francesco"'

9. The role of warm ischemia time on functional outcomes after robotic partial nephrectomy: a radionuclide renal scan study from the clock randomized trial

Author

Antonelli, Alessan dro, Cindolo, Luca, Sandri, Marco, Veccia, Alessandro, Annino, Filippo, Bertagna, Francesco, Di Maida, Fabrizio, Celia, Antonio, D’Orta, Carlo, De Concilio, Bernardino, Furlan, Maria, Giommoni, Valentina, Ingrosso, Manuela, Mari, Andrea, Nucciotti, Roberto, Olianti, Catia, Porreca, Angelo, Primiceri, Giulia, Schips, Luigi, Sessa, Francesco, Bove, Pierluigi, Simeone, Claudio, and Minervini, Andrea

Published
2023
Full Text
View/download PDF

10. Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study

Author

Bauckneht, Matteo, Miceli, Alberto, Signori, Alessio, Albano, Domenico, Capitanio, Selene, Piva, Roberta, Laudicella, Riccardo, Franchini, Annalisa, D’Amico, Francesca, Riondato, Mattia, Chiola, Silvia, Marini, Cecilia, Fornarini, Giuseppe, Scarale, Antonio, Muni, Alfredo, Bertagna, Francesco, Burger, Irene A., Sambuceti, Gianmario, and Morbelli, Silvia

Published
2023
Full Text
View/download PDF

18. Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study

Author

Cistaro, Angelina, Quartuccio, Natale, Garganese, Maria Carmen, Villani, Maria Felicia, Altini, Claudio, Pizzoferro, Milena, Piccardo, Arnoldo, Cabria, Manlio, Massollo, Michela, Maghnie, Mohamad, Campennì, Alfredo, Siracusa, Massimiliano, Baldari, Sergio, Panareo, Stefano, Urso, Luca, Bartolomei, Mirco, De Palma, Diego, Grossi, Armando, Mazzoletti, Angelica, Dondi, Francesco, Bertagna, Francesco, Giubbini, Raffaele, and Albano, Domenico

Published
2022
Full Text
View/download PDF

22. Prognostic Role of Pre- and Post-Treatment [18F]FDG PET/CT in Squamous Cell Carcinoma of the Oropharynx in Patients Treated with Chemotherapy and Radiotherapy.

Author

Dondi, Francesco, Gazzilli, Maria, Albano, Domenico, Rizzo, Alessio, Treglia, Giorgio, Pisani, Antonio Rosario, Palumbo, Carmen, Rubini, Dino, Racca, Manuela, Rubini, Giuseppe, and Bertagna, Francesco

Subjects
POSITRON emission tomography, HUMAN papillomavirus, COMPUTED tomography, SQUAMOUS cell carcinoma, OVERALL survival
Abstract

Background: The prognostic role of imaging with [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) in oropharynx cancer (OPC) has been demonstrated in the past. The aim of this study was to assess the prognostic impact of both baseline and post-treatment PET/CT in patients with OPC and treated with chemo- and/or radiotherapy. Methods: The PET/CT parameters of scans performed before and after therapy were collected and analyzed to find significant prognosticators for progression-free survival (PFS) and overall survival (OS). Human papillomavirus (HPV) infection's influence on the prognosis was also taken into account. Results: A total of 66 patients were included in the study. The staging volumetric parameters of PET/CT were significant prognosticators for OS, while the same parameters were affordable predictors for PFS at the restaging evaluation. No significant correlations between HPV infection and PET/CT parameters were reported. Conclusion: The prognostic role of volumetric [18F]FDG PET/CT parameters in patients with OPC was reported. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients

Author

Bauckneht, Matteo, Bertagna, Francesco, Donegani, Maria Isabella, Durmo, Rexhep, Miceli, Alberto, De Biasi, Vincenzo, Laudicella, Riccardo, Fornarini, Giuseppe, Berruti, Alfredo, Baldari, Sergio, Versari, Annibale, Giubbini, Raffaele, Sambuceti, Gianmario, Morbelli, Silvia, and Albano, Domenico

Published
2021
Full Text
View/download PDF

34. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation

Author

Casali, Massimiliano, Lauri, Chiara, Altini, Corinna, Bertagna, Francesco, Cassarino, Gianluca, Cistaro, Angelina, Erba, Anna Paola, Ferrari, Cristina, Mainolfi, Ciro Gabriele, Palucci, Andrea, Prandini, Napoleone, Baldari, Sergio, Bartoli, Francesco, Bartolomei, Mirco, D’Antonio, Adriana, Dondi, Francesco, Gandolfo, Patrizia, Giordano, Alessia, Laudicella, Riccardo, Massollo, Michela, Nieri, Alberto, Piccardo, Arnoldo, Vendramin, Laura, Muratore, Francesco, Lavelli, Valentina, Albano, Domenico, Burroni, Luca, Cuocolo, Alberto, Evangelista, Laura, Lazzeri, Elena, Quartuccio, Natale, Rossi, Brunella, Rubini, Giuseppe, Sollini, Martina, Versari, Annibale, and Signore, Alberto

Published
2021
Full Text
View/download PDF

38. The Potential Role of PSMA-Targeted PET in Salivary Gland Malignancies: An Updated Systematic Review.

Author

Rizzo, Alessio, Albano, Domenico, Elisei, Federica, Racca, Manuela, Dondi, Francesco, Annunziata, Salvatore, Cuzzocrea, Marco, Bertagna, Francesco, and Treglia, Giorgio

Subjects
PROSTATE-specific membrane antigen, ADENOID cystic carcinoma, POSITRON emission tomography, SALIVARY glands, COMPUTED tomography
Abstract

Background: Recent studies have suggested using positron emission tomography/computed tomography (PET/CT) with prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals for the detection of salivary gland malignancies (SGM), particularly adenoid-cystic carcinoma (ACC). Methods: The authors conducted an extensive review of the scientific literature to examine the potential diagnostic role of PET/CT using PSMA-targeting radiopharmaceuticals in salivary gland malignancies (SGMs) and adenoid cystic carcinoma (ACC). This study included newly diagnosed SGM patients and those with disease recurrence in their imaging evaluation. Results: This updated systematic review included a total of six studies that examined the diagnostic performance of PSMA-targeted PET/CT in ACC. The articles provided evidence of a high detection rate of PSMA-targeting PET/CT in ACC across all clinical contexts examined. SGMs other than ACC exhibited poorer diagnostic performance. Conclusions: PSMA-targeted PET/CT seems promising in detecting ACC lesions; moreover, PSMA appears to be a suitable potential target for radioligand therapy. Prospective multicentric studies are warranted to strengthen the role of PSMA-targeting radiopharmaceuticals in ACC, as both diagnostic and theragnostic agents. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

39. Contemporary Role of Positron Emission Tomography (PET) in Endocarditis: A Narrative Review.

Author

Sammartino, Antonio Maria, Bonfioli, Giovanni Battista, Dondi, Francesco, Riccardi, Mauro, Bertagna, Francesco, Metra, Marco, and Vizzardi, Enrico

Subjects
HEART valve prosthesis implantation, POSITRON emission tomography, INFECTIVE endocarditis, COMPUTED tomography, ARTIFICIAL implants
Abstract

Endocarditis, a serious infectious disease, remains a diagnostic challenge in contemporary clinical practice. The advent of advanced imaging modalities has contributed significantly to the improved understanding and management of this complex disease. 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) imaging has shown remarkable potential in improving the diagnostic accuracy of endocarditis. In the update of the Modified Duke Criteria, in 2023, The International Society for Cardiovascular Infectious Diseases (ISCVID) Working Group recognized specific 18F-FDG PET/CT findings as a major diagnostic criterion, particularly in patient with prosthetic valve endocarditis. The ability of PET to visualize metabolic activity allows for the identification of infective foci and could differentiate between infective and non-infective processes. This review examines the clinical utility of PET in differentiating infective endocarditis from other cardiovascular pathologies, highlighting its sensitivity and specificity in detecting native and prosthetic valve infections, including patients with transcatheter aortic valve implantation (TAVI), cardiac implantable devices (CIEDs), and left ventricular assistance devices (LVAD). Also, practical aspects and indications are illustrated to optimize the quality of imaging and reduce potential false positive results. In conclusion, the current use of PET in endocarditis has become a valuable diagnostic tool; as technological advances continue, PET will play an increasingly important role in the multidisciplinary approach to the management of endocarditis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

40. 2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome.

Author

Albano, Domenico, Calabrò, Anna, Talin, Anna, Dondi, Francesco, Pagani, Chiara, Tucci, Alessandra, Treglia, Giorgio, and Bertagna, Francesco

Subjects
PROGRESSION-free survival, BODY surface area, END of treatment, LYMPHOMAS, OVERALL survival
Abstract

This retrospective study investigated the prognostic role of disease dissemination features (Dmax and Dmaxbsa) measured by 2-[18F]FDG PET/CT in newly diagnosed Burkitt Lymphoma (BL) patients, comparing their performance with other metabolic parameters. We included 78 patients diagnosed with BL between 2010 and 2022 with an available baseline PET, interim PET/CT (iPET) and end of treatment PET/CT (eotPET) and with a minimum of two 2-[18F]FDG avid lesions present at the baseline scan. Dmax was calculated from the three-dimensional coordinates of the baseline metabolic tumor volume (MTV) by using LIFEx software; Dmaxbsa was calculated as Dmax normalized for body surface area according to the Du Bois method. We evaluated their effect on metabolic treatment response evaluated by PET, on progression free survival (PFS) and on overall survival (OS). Dmaxbsa was significantly associated with tumor stage, bulky and extranodal disease, MTV and TLG. At a median follow-up of 49 months, the median PFS and OS were 45 and 48 months. Dmax and Dmaxbsa were significantly higher in not complete metabolic response than complete metabolic response group at iPET and eotPET.As far as PFS, parameters including iPET/CT, eotPET/CT outcomes, MTV and TLG showed to be independent prognostic factors while Dmax and Dmaxbsa were not significantly associated with the outcome. Dissemination features, together with eotPET/CT results, MTV and TLG, demonstrated to be significantly correlated with OS. In conclusion, in this study we demonstrated that dissemination features derived by 2[18F]-FDG PET/CT were significantly correlated with response to treatment and long-term outcome, independently from other PET features. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

48. Response to JNC-22-024-LE

Author

Gazzilli, Maria, Albano, Domenico, Lucchini, Silvia, Peli, Alessia, Cerudelli, Elisabetta, Bertagna, Francesco, and Giubbini, Raffaele

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results